Drug Hunter Case Study Overview

The traditional way we learn about the latest in drug discovery is a conference presentation or a journal club.
You pick a colleague, ask them to spend two weeks researching a topic, and have the whole department sit in a room for an hour while your co-worker tells you what they learned.
You’d be lucky to get through one topic a quarter - IF you can find co-workers that are willing to keep volunteering to do it.
Some teams are great at keeping a habit of continuous learning alive - often in industry, everyone’s already got too many meetings to entertain another one… and the journal club dies a slow death as fewer and fewer people volunteer.
It’s frustrating because we all know how important it is as scientists to know what’s going on in industry and to stay up-to-date with modern tactics and technologies.
More than 150 biopharma companies have now replaced or supplemented their journal clubs with full access to Drug Hunter.
Drug Hunter is constantly updated with new end-to-end case studies that cover everything a drug discovery project leader wants to know:
Clinical & Competitive Landscape
Target ID
Hit-Finding
Lead Optimization
Binding Mode
Mechanism of Action
Pharmacology
Toxicology
Clinical Development
…and any other areas where there’s a valuable scientific takeaway.
These searchable case studies can be read in 10 min over coffee, lunch, or during that 30-person meeting you really didn’t need to be a part of 🙄
You probably can’t do 52 journal clubs a year, but you get that much out of skimming one Drug Hunter case study a week.
Is anyone surprised that our daily readers keep getting promoted? 💪